1. A journey of hope: lessons learned from studies on rare diseases and orphan drugs;Wästfelt;J Intern Med,2006
2. Why rare diseases are an important medical and social issue;Schieppati;Lancet,2008
3. Federal Drug Administration The Orphan Drug Act Public Law 1983 97 141 http://www.fda.gov/orphan/oda.htm
4. Two decades of orphan product development;Haffner;Nat Rev Drug Discov,2002
5. Regulation (EC) No. 141/2000 of the European Parliament and of the Council on Orphan Medicinal Products of 16 December 1999 and Commission regulation (EC) No. 847/2000 of 27 April 2000;European Union;Off J Eur Comm,2000